Description

RELIEF – CBD:THC 2:1

Widely recommended for: easing anxiety, depression, and for people living with dementia to ease symptoms of agitation, aggression, restlessness, anorexia, depression, pain, elevating mood and creating a general sense of wellbeing for those who wish to avoid many potential side effects from THC*. There is twice as much CBD as THC in Relief, which helps to mitigate unwanted effects at 6.6mgs CBD to 3.3mgs THC.

*potential side effects of THC include euphoria, increased appetite, increased nervousness, paranoia, and somnolence but are rarely reported in low doses, as recommended by a physician. It is always recommended to start with a low dose and go slow to avoid unwanted effects.

OUR CAPSULES (CAPS) each contain a specific, consistent cannabinoid dosage including a proprietary balance of natural terpene extracts. Capsules are then packaged, labeled and batch tested for accuracy, potency and potential contaminants. Delivery consists of a child-resistant zip bag containing a pharmacy style blister Pill Card, including patient-specific labels.

Whether you are a doctor, caregiver, care facility director or patient, you can be confident Farmacann products always meet or exceed the manufacturing, testing and regulatory requirements of the State of California, Medical Professionals and Licensed Care Facilities and every batch of each product receives a COA** from Anresco Laboratories in San Francisco, an industry leader since 1943, ISO 17025 accredited, FDA registered, and ELAP certified.

** A Certificate of Analysis, or COA, is a document issued by a third-party, independent testing laboratory that confirms a product meets its specification, including quantity of cannabinoids and terpenes found in each product as well as confirming that each product does not contain harmful heavy metals, pesticides, solvents, and pathogens.